These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2041861)

  • 1. Acute tubular necrosis induced by coronary thrombolytic therapy.
    Kalra PA; Coady AM; Iqbal A; Evans A; Waldek S
    Postgrad Med J; 1991 Feb; 67(784):212. PubMed ID: 2041861
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.
    Birnbaum Y; Strasberg B; Rechavia E; Neuman Y; Stahl B
    West J Med; 1993 Apr; 158(4):406-9. PubMed ID: 8317134
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypersensitive reactions on readministration of streptokinase following acute myocardial infarction.
    Sahay RN; Kalantri SP; Gupta OP
    J Assoc Physicians India; 1994 Oct; 42(10):815. PubMed ID: 7876052
    [No Abstract]   [Full Text] [Related]  

  • 4. Spontaneous haemarthrosis following thrombolytic therapy for myocardial infarction.
    Oldroyd KG; Hornung RS; Jones AM; Andrews NP; Dawes PT; Carson PH
    Postgrad Med J; 1990 May; 66(775):387-8. PubMed ID: 2371191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cholesterol embolization syndrome after intravenous streptokinase for acute myocardial infarction.
    Queen M; Biem HJ; Moe GW; Sugar L
    Am J Cardiol; 1990 Apr; 65(15):1042-3. PubMed ID: 2327344
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute iritis and transient renal impairment following thrombolytic therapy for acute myocardial infarction.
    Birnbaum Y; Barash D; Rechavia E; Regev A; Stahl B; Mager A
    Ann Pharmacother; 1993 Dec; 27(12):1539-40. PubMed ID: 8305792
    [No Abstract]   [Full Text] [Related]  

  • 7. Streptokinase-induced jaundice in patients with acute myocardial infarction.
    Mager A; Birnbaum Y; Zlotikamien B; Strasberg B; Rechavia E; Sagie A; Sclarovsky S
    Am Heart J; 1991 May; 121(5):1543-4. PubMed ID: 2017987
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary arterial aneurysm after percutaneous transluminal coronary recanalization with streptokinase.
    Chen MF; Liau CS; Lee YT
    Int J Cardiol; 1990 Jul; 28(1):117-9. PubMed ID: 2365525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute suprachoroidal haemorrhage in a patient treated with streptokinase for myocardial infarction.
    Manuchehri K; Loo A; Ramchandani M; Kirkby GR
    Eye (Lond); 1999 Oct; 13 ( Pt 5)():685-6. PubMed ID: 10696335
    [No Abstract]   [Full Text] [Related]  

  • 10. [Atheromatous material mobilization syndrome after thrombolytic therapy with streptokinase in acute myocardial infarct].
    Arpesani A; Beretta L; Giorgetti PL; Varesi C; Matturri L
    Minerva Cardioangiol; 1991 Jun; 39(6):251-4. PubMed ID: 1961445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria with streptokinase.
    Lynch M; Pentecost BL; Littler WA; Stockley RA
    Lancet; 1993 Apr; 341(8851):1024. PubMed ID: 8096904
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular complications of thrombolytic therapy in patients with a mistaken diagnosis of acute myocardial infarction.
    Blankenship JC; Almquist AK
    J Am Coll Cardiol; 1989 Nov; 14(6):1579-82. PubMed ID: 2809020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lingual hematoma due to streptokinase in a patient with acute myocardial infarction.
    Kaya A; Ordu S; Albayrak ES; Aydin M; Erden I; Ozhan H
    Am J Emerg Med; 2010 Oct; 28(8):985.e1-2. PubMed ID: 20825845
    [No Abstract]   [Full Text] [Related]  

  • 15. [Complications of thrombolytic treatment of acute myocardial infarction].
    Ugeskr Laeger; 1990 Aug; 152(33):2370-2. PubMed ID: 2219479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptokinase and low back pain.
    Bourke J
    N Z Med J; 1992 Nov; 105(946):482. PubMed ID: 1436882
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
    Ben-Chitrit S; Korzets Z; Hershkovitz R; Bernheim J; Schneider M; Bernheim J
    Nephrol Dial Transplant; 1994; 9(4):428-30. PubMed ID: 8084460
    [No Abstract]   [Full Text] [Related]  

  • 18. Spinal epidural hematoma associated with streptokinase treatment for myocardial infarction.
    Ozgocmen S; Yoldas T; Kocakoc E; Ozkurt-Zengin F; Ardicoglu O
    Spinal Cord; 2004 Jun; 42(6):374-7. PubMed ID: 14993896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-sickness-like illness as a complication after streptokinase therapy for acute myocardial infarction.
    Schweitzer DH; van der Wall EE; Bosker HA; Scheffer E; Macfarlane JD
    Cardiology; 1991; 78(1):68-71. PubMed ID: 2021968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need to identify patients who have received streptokinase therapy.
    Salem DN; Pauker SG
    N Engl J Med; 1991 Jun; 324(24):1742. PubMed ID: 2034254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.